Philippe Bergeron

Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations

Adam R. Johnson, Pawan Bir Kohli, Arna Katewa et al. · ACS Chemical Biology · 2016 · 134 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells

Michael F. T. Koehler, Philippe Bergeron, Elizabeth M. Blackwood et al. · ACS Medicinal Chemistry Letters · 2016 · 85 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

A General Version of Crow's Shadow Volumes

Philippe Bergeron · IEEE Computer Graphics and Applications · 1986 · 77 citations

Architecture, Architectural Visualization, Computational Geometry +8

Identification of <i>C</i>-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2

Mark Zak, Christopher A. Hurley, Stuart I. Ward et al. · Journal of Medicinal Chemistry · 2013 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8

Philippe Bergeron, Michael F. T. Koehler, Elizabeth M. Blackwood et al. · ACS Medicinal Chemistry Letters · 2016 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13